BACKGROUND: It has recently been suggested that Quality of Life (QOL) be used in the evaluation of new medical treatment regimens together with cost-benefit, efficacy and safety. In this overview we point out some aspects of use of the Psychological General Well-Being Index (PGWB) in patients with peptic ulcer and reflux disease gained from our own investigations in later years. METHODS: QOL was assessed using questionnaires before diagnosis, during medical healing treatment and at a 1-year follow-up in peptic ulcer disease or before and after surgery in reflux disease. RESULTS: Untreated patients with unknown diagnosis had low QOL scores. With treatment, scores increased rapidly to supernormal values and fell off to normal values during the follow-up year. CONCLUSION: QOL evaluations seem sensitive and reflect the patient's subjective feeling of disease. They add another new aspect of treatment effect not earlier included in treatment evaluations.
BACKGROUND: It has recently been suggested that Quality of Life (QOL) be used in the evaluation of new medical treatment regimens together with cost-benefit, efficacy and safety. In this overview we point out some aspects of use of the Psychological General Well-Being Index (PGWB) in patients with peptic ulcer and reflux disease gained from our own investigations in later years. METHODS: QOL was assessed using questionnaires before diagnosis, during medical healing treatment and at a 1-year follow-up in peptic ulcer disease or before and after surgery in reflux disease. RESULTS: Untreated patients with unknown diagnosis had low QOL scores. With treatment, scores increased rapidly to supernormal values and fell off to normal values during the follow-up year. CONCLUSION: QOL evaluations seem sensitive and reflect the patient's subjective feeling of disease. They add another new aspect of treatment effect not earlier included in treatment evaluations.
Authors: Leah Kleinman; Anne Kilburg; Gerardo Machnicki; Randall Faull; Rowan Walker; Ramesh Prasad; Patrice Ambuehl; Udo Bahner; Mary Kay Margolis Journal: Qual Life Res Date: 2006-09-14 Impact factor: 4.147
Authors: A M Rentz; C Battista; E Trudeau; R Jones; P Robinson; S Sloan; S Mathur; L Frank; D A Revicki Journal: Pharmacoeconomics Date: 2001 Impact factor: 4.981
Authors: Caroline M den Hoed; Kees Isendoorn; Wouter Klinkhamer; Anshu Gupta; Ernst J Kuipers Journal: United European Gastroenterol J Date: 2013-10 Impact factor: 4.623
Authors: Dennis A Revicki; Marc W Zodet; Sandra Joshua-Gotlib; Douglas Levine; Joseph A Crawley Journal: Health Qual Life Outcomes Date: 2003-11-29 Impact factor: 3.186